Qube Research & Technologies (QRT)
ETNB

Qube Research & Technologies (QRT)’s 89bio ETNB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-90,909
Closed -$1.34M – 3781
2025
Q3 		$1.34M Buy
+90,909
New +$927K ﹤0.01% 2402
2025
Q2 		– Sell
-176,834
Closed -$1.29M – 3656
2025
Q1 		$1.29M Buy
+176,834
New +$1.55M ﹤0.01% 2154
2024
Q2 		– Sell
-17,100
Closed -$199K – 4056
2024
Q1 		$199K Sell
17,100
-386,224
-96% -$4.28M ﹤0.01% 3024
2023
Q4 		$4.51M Buy
+403,324
New +$3.71M 0.01% 1093
2023
Q3 		– Sell
-71,754
Closed -$1.36M – 4140
2023
Q2 		$1.36M Buy
71,754
+3,223
+5% +$56.6K ﹤0.01% 1186
2023
Q1 		$1.04M Buy
68,531
+11,855
+21% +$155K ﹤0.01% 1274
2022
Q4 		$721K Buy
56,676
+39,893
+238% +$359K ﹤0.01% 1350
2022
Q3 		$97K Buy
+16,783
New +$73.7K ﹤0.01% 1978

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ETNB Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of 89bio (ETNB) in Q4 2025, closing a stake of 90,909 shares — an estimated $1.34M sold.

Qube Research & Technologies (QRT) first reported a position in ETNB in Q3 2022 and held it in 8 quarters. The position peaked at $4.51M in Q4 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 90,909 89bio shares in Q4 2025, an estimated $1.34M.
  • Qube Research & Technologies (QRT) first reported a position in 89bio in Q3 2022 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s 89bio position peaked at $4.51M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.